ydus has received marketing approval from Mexican regulatory authority COFEPRIS for Mamitra, a Trastuzumab biosimilar. #FinancialNews #Trading  ydus has received marketing approval from Mexican regulatory authority COFEPRIS for Mamitra, a Trastuzumab biosimilar. #FinancialNews #Trading
Related Posts
Global Indices GIFT Nifty: 22686 +106 Hangseng: 18475 -64 Dow: 22693 +450 S&P 500: 5127 +64 Nasdaq: 16156 +315 USD / INR: 83.43 Brent Crude: 89.29 GOLD: 2321.75 FII Net (03-04-2024): -2392 DII Net (03-04-2024): +691 Global Indices GIFT Nifty: 22686 +106 Hangseng: 18475 -64 Dow: 22693 +450 S&P 500: 5127 +64 Nasdaq: 16156 +315 USD / INR: 83.43 Brent Crude: 89.29 GOLD: 2321.75 FII Net (03-04-2024): -2392 DII Net (03-04-2024): +691
- Raj Gaurav Rai
- May 6, 2024
Global Indices GIFT Nifty: 22686 +106Hangseng: 18475 -64Dow: 22693 +450S&P 500: 5127 +64Nasdaq: 16156 +315USD / INR: 83.43Brent Crude: 89.29GOLD: 2321.75FII Net (03-04-2024): -2392DII Net […]
NIFTY VIEW: Nifty have failed to hold on to the gains. The support for the index is around 23050 now and resistance is at 23450 levels. BANKNIFTY VIEW: The index will undergo its weekly expiry today and is expected to remain volatile. The key support for the index is around 49400 while resistance is at 50000 levels. FINNIFTY VIEW: FINNIFTY is having crucial support around 22000 on the lower side while resistance is at 22350-22400 for the day FinancialNews #StockMarket NIFTY VIEW: Nifty have failed to hold on to the gains. The support for the index is around 23050 now and resistance is at 23450 levels. BANKNIFTY VIEW: The index will undergo its weekly expiry today and is expected to remain volatile. The key support for the index is around 49400 while resistance is at 50000 levels. FINNIFTY VIEW: FINNIFTY is having crucial support around 22000 on the lower side while resistance is at 22350-22400 for the day FinancialNews #StockMarket
- Raj Gaurav Rai
- June 12, 2024
NIFTY VIEW: Nifty have failed to hold on to the gains. The support for the index is around 23050 now and resistance is at 23450 […]
AARTI INDUSTRIES पर मॉर्गन स्टैनली ने आरती इंडस्ट्रीज पर ओवरवेट रेटिंग देकर इसके शेयर का लक्ष्य 575 रुपये/प्रति शेयर तय किया है। उनका कहना है कि कंपनी ने 6,000 करोड़ रुपये का एक और कॉन्ट्रैक्ट किया है। लंबी अवधि के कॉन्ट्रैक्ट पर हस्ताक्षर करना प्रोडक्ट डिमांड को दर्शाता है। पिछले दो महीनों में कंपनी द्वारा घोषित यह दूसरा लॉन्गटर्म कॉन्ट्रैक्ट है
- Raj Gaurav Rai
- January 20, 2024
AARTI INDUSTRIES पर मॉर्गन स्टैनली ने आरती इंडस्ट्रीज पर ओवरवेट रेटिंग देकर इसके शेयर का लक्ष्य 575 रुपये/प्रति शेयर तय किया है। उनका कहना है […]